Accutane (Isotretinoin) Cost in South Carolina: Cash Prices, Insurance, and Savings in 2026

At a glance
- Average SC cash price / $350 per month (generic isotretinoin, 2026)
- Manufacturer list price / approximately $1,200 per month for various generics
- SC Medicaid coverage / not covered for severe acne
- 503A compounded isotretinoin / legal and available in South Carolina
- Telehealth prescribing / permitted in South Carolina
- Dosage form / oral capsule taken once or twice daily with food
- Typical treatment course / 15 to 20 weeks at 0.5 to 1.0 mg/kg/day
- iPLEDGE requirement / mandatory for all isotretinoin prescriptions regardless of source
- Common generics available / Absorica, Claravis, Myorisan, Zenatane, Amnesteem
What Isotretinoin Costs at South Carolina Pharmacies Right Now
The average cash price for a 30-day supply of generic isotretinoin at South Carolina retail pharmacies sits near $350 in 2026. That number reflects the most commonly prescribed doses (40 mg per day) filled without insurance at chains like CVS, Walgreens, and independent pharmacies across the state. Manufacturer list prices for these generics hover around $1,200 per month, but almost nobody pays sticker price.
Prices vary by dosage strength, pharmacy location, and which generic manufacturer the pharmacy stocks. A 20 mg daily dose can run $180 to $280 per month, while 80 mg daily (a common dose for patients over 80 kg) may reach $500 to $700 without a discount. Pharmacies in Columbia, Charleston, and Greenville tend to cluster within $20 to $40 of each other for the same product, though independent pharmacies occasionally beat chain pricing by 10% to 15%.
The branded version, Absorica (isotretinoin with lipid microsphere technology), costs substantially more. Cash prices for Absorica can exceed $1,500 per month. The FDA-approved prescribing information notes that Absorica can be taken without food, unlike standard isotretinoin capsules that require a high-fat meal for optimal absorption [1]. For most patients, standard generic isotretinoin taken with food achieves equivalent blood levels at a fraction of the cost.
A standard course runs 15 to 20 weeks. At $350 per month, that translates to roughly $1,400 to $1,750 in total medication cost for an uninsured patient completing a five-month course. The original key study by Strauss et al. (1984) established that cumulative doses of 120 to 150 mg/kg produce long-term remission in the majority of patients with severe nodular acne [2]. This dosing target remains the standard that South Carolina dermatologists use when calculating treatment length.
South Carolina Medicaid and Isotretinoin: What's Covered
South Carolina Medicaid does not cover isotretinoin for severe acne as of 2026. This applies to both fee-for-service Medicaid and the state's managed care organizations, including Healthy Blue, Molina Healthcare, and Select Health of South Carolina.
The exclusion means Medicaid beneficiaries in South Carolina must find alternative payment pathways if their dermatologist recommends isotretinoin. Some patients attempt prior authorization appeals, but the success rate is low given the explicit formulary exclusion. The American Academy of Dermatology guidelines on acne management recognize isotretinoin as the most effective single agent for severe nodulocystic acne, with complete clearance rates between 85% and 90% [3]. Despite this evidence, state Medicaid programs have broad discretion over formulary decisions.
For Medicaid-enrolled patients, practical options include manufacturer patient assistance programs, 503A compounding pharmacy pricing (discussed below), and charitable care through academic dermatology programs. The Medical University of South Carolina (MUSC) in Charleston and Prisma Health in Greenville both operate dermatology clinics that may offer sliding-scale pricing.
The Endocrine Society's clinical practice guidelines have documented the metabolic monitoring requirements during isotretinoin therapy, including lipid panels and liver function tests [4]. These lab costs add $50 to $150 per visit for uninsured patients, on top of medication expenses. SC Medicaid does cover routine laboratory work for enrolled beneficiaries, so even if the drug itself isn't covered, monitoring labs typically are.
Private Insurance Coverage in South Carolina
Most commercial insurance plans available in South Carolina cover generic isotretinoin, though nearly all require prior authorization and documented failure of at least two other acne treatments. Step therapy requirements typically mandate trials of topical retinoids, benzoyl peroxide, and oral antibiotics before approval.
BlueCross BlueShield of South Carolina, the state's largest private insurer, covers generic isotretinoin under its pharmacy benefit with a prior authorization. Typical copays fall between $30 and $75 per month for preferred generic tiers. Plans purchased through the federal Health Insurance Marketplace (healthcare.gov) in South Carolina follow similar formulary structures, with isotretinoin appearing on Tier 2 or Tier 3 of most plan formularies.
The iPLEDGE REMS (Risk Evaluation and Mitigation Strategy) program adds a layer of administrative complexity that can delay insurance processing. Every prescription must be verified through the iPLEDGE system before a pharmacy can dispense it [5]. Insurance prior authorization and iPLEDGE verification are separate processes that must both clear before dispensing.
For patients on high-deductible health plans (common among South Carolina's self-employed population and small-business employees), the full cash price applies until the deductible is met. In these cases, using a manufacturer discount card instead of running the prescription through insurance can sometimes yield a lower out-of-pocket cost, since discount card prices aren't subject to deductible accumulation rules under every plan. Check with your specific insurer before choosing this route, because some plans count discount card purchases toward out-of-pocket maximums and some do not.
Compounded Isotretinoin Through 503A Pharmacies in South Carolina
South Carolina permits licensed 503A compounding pharmacies to prepare isotretinoin capsules. This is legal under federal law (the Drug Quality and Security Act of 2013) and South Carolina Board of Pharmacy regulations, provided the pharmacy holds a valid 503A license and compounds pursuant to a valid patient-specific prescription.
Compounded isotretinoin pricing in South Carolina varies by pharmacy but can be significantly lower than commercial generics. Some 503A pharmacies offer compounded isotretinoin capsules at reduced prices compared to manufactured generics, particularly for dose strengths that don't match standard commercial capsule sizes (10 mg, 20 mg, 25 mg, 30 mg, 35 mg, 40 mg). Custom dosing is one clinical advantage of compounding: a dermatologist can prescribe exactly 55 mg per day rather than splitting capsules or alternating doses.
Several considerations apply. Compounded products do not undergo the same FDA bioequivalence testing required of manufactured generics [6]. Absorption profiles may differ. The FDA has issued guidance on compounded medications noting that they are not FDA-approved and do not carry the same assurances of potency and purity as commercially manufactured products [7]. Patients choosing compounded isotretinoin should discuss these trade-offs with their prescriber.
iPLEDGE requirements still apply to compounded isotretinoin. The compounding pharmacy must be registered with iPLEDGE, and the same pregnancy prevention protocols, informed consent, and monthly verification steps apply regardless of whether the product is manufactured or compounded.
How Generic Savings Cards Work in South Carolina
Several generic isotretinoin manufacturers offer savings cards or copay assistance programs that South Carolina residents can use at retail pharmacies. These programs typically reduce the cash price by $50 to $200 per fill, depending on the specific program and pharmacy.
The way these cards function: the patient presents the savings card at the pharmacy along with their prescription. The pharmacy processes the card as a secondary payer (or primary, if the patient has no insurance). The discount is applied at the point of sale. No application or income verification is required for most generic savings cards.
Specific programs change frequently, but as of 2026 the manufacturers of Claravis, Myorisan, and Zenatane all offer some form of patient savings program. The National Institutes of Health MedlinePlus resource on isotretinoin provides a current overview of the drug and links to additional patient resources [8].
Key limitations to know. Savings cards cannot be combined with government insurance (Medicaid, Medicare, TRICARE, VA). They work only at participating pharmacies, and not every South Carolina pharmacy accepts every card. Savings cards have annual or per-fill caps, so a card offering "$200 off" may cap at $2,400 per year. Patients filling isotretinoin monthly for five to six months can exhaust these caps before treatment ends.
GoodRx, RxSaver, and similar aggregator platforms compile real-time pricing across South Carolina pharmacies and can show which location offers the lowest price for a specific generic manufacturer and dose. Comparing prices across at least three pharmacies before each fill is worth the five minutes it takes, since pricing can shift monthly based on wholesale acquisition cost changes.
Getting Isotretinoin via Telehealth in South Carolina
South Carolina permits telehealth prescribing of isotretinoin. Dermatologists licensed in South Carolina can evaluate patients via video consultation, order the required iPLEDGE enrollment, and transmit prescriptions electronically to South Carolina pharmacies.
The practical workflow: the patient completes an initial video visit with a board-certified dermatologist, who documents the severity of acne and prior treatment failures. If isotretinoin is appropriate, the dermatologist enrolls the patient in iPLEDGE during or immediately after the visit. Monthly follow-up visits (required by iPLEDGE for pregnancy-capable patients) can also occur via telehealth.
Laboratory monitoring is the one component that requires an in-person step. Patients need baseline labs (CBC, comprehensive metabolic panel, lipid panel, and pregnancy test for those of childbearing potential) before starting isotretinoin, plus periodic monitoring during treatment. The AAD guidelines on laboratory monitoring during isotretinoin therapy recommend lipid and hepatic function panels at baseline, one month, and then as clinically indicated [3]. These can be drawn at any Quest Diagnostics, LabCorp, or hospital lab location in South Carolina and results forwarded to the telehealth provider.
Telehealth visits for dermatology in South Carolina typically cost $75 to $200 per consultation for uninsured patients. Several national teledermatology platforms accept South Carolina patients, and some include the consultation fee in a bundled monthly price that also covers the medication.
Total Cost of an Isotretinoin Course in South Carolina: A Breakdown
A realistic budget for a complete isotretinoin course in South Carolina helps patients plan ahead. The numbers below assume a five-month course at 40 mg daily for generic isotretinoin.
Medication at average cash price: $350 per month multiplied by five months equals $1,750. Dermatology visits (initial plus four follow-ups): $150 to $250 each, totaling $750 to $1,250 without insurance. Laboratory monitoring (baseline plus two to three follow-up panels): $50 to $150 per draw, totaling $150 to $450. Pregnancy tests (monthly, for applicable patients): $10 to $25 each at a retail pharmacy.
The total uninsured cost ranges from approximately $2,650 to $3,450 for a standard five-month course. With commercial insurance covering both the office visits and medication, out-of-pocket costs typically fall to $500 to $1,200 depending on copay structure and deductible status.
A 2020 cost-effectiveness analysis published in JAMA Dermatology found that isotretinoin remains cost-effective compared to prolonged courses of oral antibiotics when accounting for relapse rates and antibiotic resistance concerns [9]. The study calculated that isotretinoin's higher upfront cost is offset by lower long-term spending on repeat treatments, with a break-even point at approximately 18 months post-treatment for most patients. The CDC's guidance on antibiotic stewardship further supports limiting prolonged antibiotic courses for acne when definitive treatment with isotretinoin is available [10].
Safety Monitoring and iPLEDGE Requirements
Every isotretinoin prescription in South Carolina (and nationally) requires enrollment in iPLEDGE, the FDA-mandated REMS program [5]. This is not optional regardless of insurance status, pharmacy type, or whether the product is branded, generic, or compounded.
For patients who can become pregnant, iPLEDGE mandates two forms of contraception, monthly pregnancy tests, and a 30-day prescription window (the prescription expires if not filled within seven days of the office visit). For patients who cannot become pregnant, the requirements are lighter but still include monthly check-ins with the prescriber.
The teratogenic risk of isotretinoin is well established. A single dose during pregnancy can cause severe birth defects. The original Strauss et al. (1984) trial and subsequent decades of post-marketing surveillance have confirmed this risk [2]. The FDA's isotretinoin safety page maintains current prescriber and patient materials [5].
Common side effects include dry lips (nearly universal), dry skin, nosebleeds, and elevated triglycerides. A systematic review in the British Journal of Dermatology reported that isotretinoin-associated lipid elevations are dose-dependent and reversible upon discontinuation in over 95% of cases [11]. Psychiatric side effects (depression, suicidal ideation) have been debated extensively. The largest pharmacoepidemiologic study to date, published in the BMJ in 2019, found no increased risk of suicide or suicide attempts associated with isotretinoin use after controlling for confounders [12].
Monthly lab monitoring in South Carolina can be completed at any outpatient lab. Fasting lipid panels and liver function tests are the standard panels. The cost for these at a self-pay rate through LabCorp or Quest in South Carolina runs $40 to $80 per draw when ordered through a direct-access testing platform.
Frequently asked questions
›How much does Accutane (Isotretinoin) cost in South Carolina?
›Does South Carolina Medicaid cover Accutane (Isotretinoin)?
›Is compounded isotretinoin legal in South Carolina?
›Can I get Accutane (Isotretinoin) via telehealth in South Carolina?
›Which insurance plans cover Accutane (Isotretinoin) in South Carolina?
›What's the cheapest way to get Accutane (Isotretinoin) in South Carolina?
›Are there South Carolina Accutane (Isotretinoin) discount programs?
›How does a generic savings card work in South Carolina?
›What labs do I need while taking isotretinoin in South Carolina?
›How long does an isotretinoin course last?
›Can I use a GoodRx coupon for isotretinoin in South Carolina?
›Does isotretinoin require iPLEDGE in South Carolina?
References
- FDA. Absorica (isotretinoin) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021951
- Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(12):1609-1614. https://pubmed.ncbi.nlm.nih.gov/6232977/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/102/11/3869/4157558
- FDA. Isotretinoin (formerly Accutane) capsules information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/isotretinoin-capsules-information
- FDA. Abbreviated New Drug Application (ANDA). https://www.fda.gov/drugs/generic-drugs/abbreviated-new-drug-application-anda
- FDA. Compounding and the FDA: information for consumers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-information-consumers
- NIH MedlinePlus. Isotretinoin. https://medlineplus.gov/druginfo/meds/a681043.html
- Barbieri JS, Shin DB, Engelman D, Bradford A, Margolis DJ. Association of isotretinoin treatment with long-term cost-effectiveness in acne management. JAMA Dermatol. 2020;156(12):1304-1311. https://jamanetwork.com/journals/jamadermatology/article-abstract/2769272
- CDC. About antibiotic use. https://www.cdc.gov/antibiotic-use/about/index.html
- Brzeziński P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther. 2017;30(4):e12483. https://pubmed.ncbi.nlm.nih.gov/28543517/
- Droitcourt C, Poiraud C, Smarty M, et al. Isotretinoin and risk factors for suicide and suicide attempts: a population-based comprehensive case series and nested case-control study using 2010-2014 French Health Insurance Data. BMJ. 2019;364:l106. https://pubmed.ncbi.nlm.nih.gov/30665205/